Search results for: 'engineering research and development'

This Frost & Sullivan study provides an overview of the research and development (R&D) budget of the US Department of Defense (DoD) for the period between FY2023 and FY2029. The study outlines the DoD’s budget activities and funding distribution amongst military branches and provides a forecast with spending estimates. It highlights the trends infl...

This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery a...

05 Aug 2024  |  Global  |  Technology Research

CGT Research Outlook and Technology Growth Opportunities

CGT Landscape Assessment

Infographics

×

The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...

This study covers engineered wood (EW) products (including plywood, oriented strand board (OSB), laminated veneer lumber (LVL), cross-laminated timber (CLT), medium- and high-density fiberboard (MDF, HDF), particleboard (or chipboard), glued laminated timber (glulam), and hardboard) and bonding agents (including melamine-urea-formaldehyde (MUF), ph...

The SynBio field has evolved well over the past two decades, with significant technology disruptions leading to new opportunities and remarkable growth potential. Advances in SynBio technologies have transformed drug discovery and therapeutics development, accelerating the identification of novel drug targets and high-throughput compound screening ...

This issue of High-Tech Materials Technology Opportunity Engine (TOE) profiles significant advancements in advanced materials for various enhanced industrial applications. The featured innovations include Dynamic Polymer Chemistry for Recyclable Composite Materials, Biodegradation Technology for Plastic Waste Management, Shape Memory Polymers for V...

02 Sep 2025  |  Global  |  Technology Research

Technological Advances in Engineered Cell Therapies, Global, 2025–2029

Emerging Trends and Technologies in Engineered Cell Therapies

Infographics

×

Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....